Rama Vision Limited (RAMAVISION.BO)
INR 79.17
(-2.26%)
INR 79.17
(-2.26%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 67.79 Million INR | 40.81% |
| 2022 | 47.12 Million INR | 81.44% |
| 2021 | 26.42 Million INR | -0.75% |
| 2020 | 25.81 Million INR | 58.63% |
| 2019 | 14.66 Million INR | 6.95% |
| 2018 | 15.35 Million INR | 154.1% |
| 2017 | 10.32 Million INR | 90.94% |
| 2016 | 3.13 Million INR | 155.94% |
| 2015 | -5.09 Million INR | -134.34% |
| 2014 | 14.49 Million INR | 69.29% |
| 2013 | 9.82 Million INR | 22.65% |
| 2012 | 7.83 Million INR | 3.67% |
| 2011 | 7.55 Million INR | 14.98% |
| 2010 | 6.56 Million INR | 503.56% |
| 2009 | -1.62 Million INR | -115.77% |
| 2008 | 10.32 Million INR | -25.17% |
| 2007 | 13.79 Million INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 24.19 Million INR | 17.72% |
| 2023 Q4 | 20.15 Million INR | 6.28% |
| 2023 Q3 | 18.96 Million INR | 27.02% |
| 2023 FY | - INR | 40.81% |
| 2023 Q2 | 14.93 Million INR | 19.12% |
| 2023 Q1 | 12.53 Million INR | 22.54% |
| 2022 Q2 | 12.7 Million INR | 12.92% |
| 2022 FY | - INR | 81.44% |
| 2022 Q4 | 10.22 Million INR | -15.69% |
| 2022 Q3 | 12.13 Million INR | -4.47% |
| 2022 Q1 | 11.24 Million INR | 31.16% |
| 2021 FY | - INR | -0.75% |
| 2021 Q4 | 8.57 Million INR | 7.16% |
| 2021 Q1 | 4.03 Million INR | -65.19% |
| 2021 Q2 | 4.9 Million INR | 21.58% |
| 2021 Q3 | 8 Million INR | 63.04% |
| 2020 Q1 | 4.7 Million INR | 9.18% |
| 2020 FY | - INR | 58.63% |
| 2020 Q4 | 11.59 Million INR | 129.75% |
| 2020 Q3 | 5.04 Million INR | 15.59% |
| 2020 Q2 | 4.36 Million INR | -7.09% |
| 2019 Q1 | 4.41 Million INR | 58.97% |
| 2019 Q4 | 4.3 Million INR | 25.18% |
| 2019 FY | - INR | 6.95% |
| 2019 Q2 | 4.05 Million INR | -8.14% |
| 2019 Q3 | 3.43 Million INR | -15.17% |
| 2018 Q2 | 4.01 Million INR | 4.2% |
| 2018 Q1 | 3.85 Million INR | 337.58% |
| 2018 Q4 | 2.77 Million INR | -38.41% |
| 2018 FY | - INR | 154.1% |
| 2018 Q3 | 4.5 Million INR | 12.17% |
| 2017 Q4 | -1.62 Million INR | -179.68% |
| 2017 Q2 | 8.24 Million INR | 306.18% |
| 2017 Q1 | -3.99 Million INR | -1638.08% |
| 2017 FY | - INR | 90.94% |
| 2017 Q3 | 2.03 Million INR | -75.29% |
| 2016 Q1 | 2.69 Million INR | 226.5% |
| 2016 FY | - INR | 155.94% |
| 2016 Q4 | 260 Thousand INR | 185.53% |
| 2016 Q3 | -304 Thousand INR | -127.71% |
| 2016 Q2 | 1.09 Million INR | -59.25% |
| 2015 FY | - INR | -134.34% |
| 2015 Q4 | -2.12 Million INR | -17.31% |
| 2015 Q3 | -1.81 Million INR | -16.66% |
| 2015 Q2 | -1.55 Million INR | -482.06% |
| 2015 Q1 | 407 Thousand INR | 20.59% |
| 2014 Q2 | 5.59 Million INR | 22.48% |
| 2014 FY | - INR | 69.29% |
| 2014 Q4 | 337.52 Thousand INR | -90.9% |
| 2014 Q3 | 3.7 Million INR | -33.71% |
| 2014 Q1 | 4.56 Million INR | 26.84% |
| 2013 FY | - INR | 22.65% |
| 2013 Q1 | -1.8 Million INR | -184.99% |
| 2013 Q2 | 2.09 Million INR | 216.26% |
| 2013 Q3 | 2.65 Million INR | 26.78% |
| 2013 Q4 | 3.6 Million INR | 35.59% |
| 2012 Q3 | 2.65 Million INR | 165.07% |
| 2012 Q4 | 2.12 Million INR | -20.17% |
| 2012 FY | - INR | 3.67% |
| 2012 Q1 | 2.76 Million INR | 179.41% |
| 2012 Q2 | 1 Million INR | -63.74% |
| 2011 Q2 | 3.6 Million INR | 16.77% |
| 2011 Q1 | 3.08 Million INR | 0.0% |
| 2011 FY | - INR | 14.98% |
| 2011 Q4 | -3.47 Million INR | -194.16% |
| 2011 Q3 | 3.69 Million INR | 2.64% |
| 2010 FY | - INR | 503.56% |
| 2009 FY | - INR | -115.77% |
| 2008 Q4 | 5.59 Million INR | 0.0% |
| 2008 FY | - INR | -25.17% |
| 2007 FY | - INR | 0.0% |
| 2007 Q4 | 2.35 Million INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Chandra Bhagat Pharma Limited | 36.55 Million INR | -85.44% |
| Checkpoint Trends Limited | 297.07 Thousand INR | -22720.547% |
| Everest Organics Limited | 118.72 Million INR | 42.9% |
| GUJARAT INJECT (KERALA) LTD. | 1.05 Million INR | -6340.351% |
| NATURO INDIABULL LIMITED | 14.68 Million INR | -361.585% |
| NEXUS SURGICAL AND MEDICARE LI | 2.98 Million INR | -2173.455% |
| Rajnish Wellness Limited | 19.93 Million INR | -240.002% |
| Vivo Bio Tech Limited | 212.99 Million INR | 68.172% |